On May 1, 2017, Congress released the FY 2017 Omnibus bill (and explanatory statements), which provides funding for the U.S. government through the rest of the fiscal year including for U.S. global health programs at the U.S. Agency for International Development (USAID), the Department of State, and the Centers for Disease Control and Prevention (CDC). Total known* funding for U.S. global health programs in the FY 2017 Omnibus is $9.4 billion, which is approximately $235 million (2.6%) higher than the FY 2016 enacted level. The tables below compare U.S. global health funding in the FY 2017 Omnibus to the FY 2016 enacted levels, the House and Senate FY17 appropriations bills, and proposed cuts submitted by the Administration to Congress in March 2017.

Funding for tuberculosis, malaria, maternal & child health (MCH), vulnerable children, and global health security increased compared to FY 2016. The entire global health security increase is for an “Emergency Reserve Fund” to respond to emerging threats, while a majority of the increase in MCH funding was for an increased contribution to Gavi, the Vaccine Alliance. Funding for all other global health programs (HIV, neglected tropical diseases, nutrition, and family planning & reproductive health) remained flat compared to FY 2016 levels.

*Some funding amounts (e.g. NIH funding for international HIV research) are determined at the agency level, and were not earmarked by Congress in the Omnibus bill.